raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:431361

Progressive encephalopathy with leukodystrophy due to DECR deficiency

Synonyms: 2,4-dienoyl-CoA reductase deficiency · DECR deficiency with hyperlysinemia

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

Progressive encephalopathy with leukodystrophy due to DECR deficiency is a rare mitochondrial disease, which presents with neonatal hypotonia, central nervous system abnormalities (ventriculomegaly, corpus callosum hypoplasia, cerebellar atrophy), acquired microcephaly, failure to thrive, developmental delay and intermittent lactic acidosis provoked by catabolic stress (e.g. infection). Hyperlysinemia and elevated C10:2 carnitine can be detected in plasma. Later on, epilepsy, cerebellar ataxia, renal tubular acidosis, severe encephalopathy, dystonia, spastic quadriplegia and other complications may develop.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enProgressive encephalopathy with leukodystrophy due to DECR deficiency2,4-dienoyl-CoA reductase deficiency · DECR deficiency with hyperlysinemia
frEncéphalopathie progressive avec leucodystrophie par déficit en DECRDéficit en 2,4-dienoyl-CoA réductase · Déficit en DECR avec hyperlysinémie
deProgressive Enzephalopathie mit Leukodystrophie durch DECR-Mangel2,4-Dienoyl-CoA-Reductase-Mangel · DECR-Mangel mit Hyperlysinämie
esEncefalopatía progresiva con leucodistrofia por deficiencia de DECRDeficiencia de 2,4-dienoil-CoA reductasa · Deficiencia de DECR con hiperlisinemia
itEncefalopatia progressiva con leucodistrofia da deficit di DECRDeficit di 2,4-dienoil-CoA reduttasi · Deficit di DECR con iperlisinemia
nlProgressieve encefalopathie met leukodystrofie door DECR-deficiëntie2,4-dienoyl-CoA-reductasedeficiëntie · DECR-deficiëntie met hyperlysinemie
ptEncefalopatia progressiva com leucodistrofia por défice de DECR
plPostępująca encefalopatia z leukodystrofią spowodowaną niedoborem DECRNiedobór DECR z hiperlizynemią · Niedobór reduktazy 2,4-dienoilo-CoA
csProgresivní encefalopatie s leukodystrofií způsobená deficitem DECRDeficit 2,4-dienoyl-CoA reduktázy · Deficit DECR s hyperlysinemií
ukПрогресуюча енцефалопатія з лейкодистрофією, зумовлена дефіцитом DECRДефіцит 2,4-дієнозил-КоА-редуктази · Дефіцит DECR з гіперлізинемією
zhDECR缺乏所致进行性脑病伴脑白质营养不良2,4-二烯酰辅酶A还原酶缺乏症
trDECR eksikliğine bağlı lökodistrofi ile seyreden ilerleyici ensefalopatiHiperlizinemi ile seyreden DECR eksikliği · 2,4-dienoil-CoA redüktaz eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616034Evalidated
ICD-10G31.8NTBTattributedvalidated
ICD-118A44.3NTBTattributedvalidated
MONDO0014464Evalidated
MeSHC565624Evalidated
UMLSC1857252Evalidated
GARD10327Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NADK2Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:26404ENSG000001526206157875p13.2NAD kinase 2, mitochondrial24847004[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated24847004[PMID]_2332510[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_24847004[PMID]_2332510[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

28 annotations · validated 2018-03-14
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012751Abnormal basal ganglia MRI signal intensity
HP:0010967Abnormal circulating carnitine concentration
HP:0012547Abnormal involuntary eye movements
HP:0011951Aspiration pneumonia
HP:0010536Central sleep apnea
HP:0001272Cerebellar atrophy
HP:0100704Cerebral visual impairment
HP:0001266Choreoathetosis
HP:0003206Decreased activity of NADPH oxidase
HP:0003234Decreased circulating carnitine concentration
HP:0001332Dystonia
HP:0001508Failure to thrive
HP:0001263Global developmental delay
HP:0002161Hyperlysinemia
HP:0002079Hypoplasia of the corpus callosum
HP:0002415Leukodystrophy
HP:0000252Microcephaly
HP:0001319Neonatal hypotonia
HP:0002470Nonprogressive cerebellar ataxia
HP:0000639Nystagmus
HP:0001992Organic aciduria
HP:0001733Pancreatitis
HP:0002448Progressive encephalopathy
HP:0002478Progressive spastic quadriplegia
HP:0001947Renal tubular acidosis
HP:0001250Seizure
HP:0004897Stress/infection-induced lactic acidosis
HP:0002119Ventriculomegaly

Annotation source: 24847004[PMID]_2332510[PMID]

7

Sources for this card